Minimal residual disease response-adapted therapy in newly diagnosed multiple myeloma (MASTER): final report of the multicentre, single-arm, phase 2 trial
| Autor: | Costa, Luciano J *, Chhabra, Saurabh, Medvedova, Eva, Dholaria, Bhagirathbhai R, Schmidt, Timothy M, Godby, Kelly N, Silbermann, Rebecca, Dhakal, Binod, Bal, Susan, Giri, Smith, D'Souza, Anita, Hall, Aric C, Hardwick, Pamela, Omel, James, Cornell, Robert F, Hari, Parameswaran, Callander, Natalie S |
|---|---|
| Zdroj: | In The Lancet Haematology November 2023 10(11):e890-e901 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|